Pulmonary arterial hypertension and portal hypertension in a patient with hereditary hemorrhagic telangiectasia

Med Clin (Barc). 2015 Mar 15;144(6):261-4. doi: 10.1016/j.medcli.2014.09.024. Epub 2014 Dec 24.

Abstract

Background and objective: Pulmonary arterial hypertension (PAH) is a rare disease that could be inherited with an autosomal dominant pattern. Mutations in BMPR2 gene are described in over 70% of cases, although other genes are involved in lesser extend in PAH. Hereditary hemorrhagic telangiectasia (HHT) is another rare autosomal dominant disease. PAH is a rare complication of HHT that occurs in less than 1% of cases. Liver cirrhosis with portal hypertension is also associated with the presence of PAHs in 1-2% of cases.

Patients: We present here a patient with HHT who developed PAH shortly after showing portal hypertension.

Results: Some genes (BMPR2, ACVRL1, ENG) seem to play an important role in PAH pathogenesis. We analyzed these genes, detecting mutations in BMPR2 gene (c.1021G>A (V341L), c.327G>A (p.Q109Q)), ACVRL1 (c.313+20C>A, c.1502+7A>G) and ENG (c.498G>A (Q166Q)). The patient also had 3 polymorphisms in the TRPC6 gene (c.1-361A>T, c.1-254C>G, c.1-218C>T).

Conclusions: The study of these genes will help us to identify and track individuals susceptible for developing PAH associated with other diseases.

Keywords: Hereditary hemorrhagic telangiectasia; Hipertensión arterial pulmonar; Hipertensión portal; Mutaciones; Mutations; Portal hypertension; Pulmonary arterial hypertension; Telangiectasia hemorrágica hereditaria.

Publication types

  • Case Reports

MeSH terms

  • Activin Receptors, Type II / genetics
  • Antigens, CD / genetics
  • Bone Morphogenetic Protein Receptors, Type II / genetics
  • Endoglin
  • Fatal Outcome
  • Genetic Markers
  • Genetic Predisposition to Disease
  • Humans
  • Hypertension, Portal / diagnosis
  • Hypertension, Portal / etiology*
  • Hypertension, Pulmonary / diagnosis
  • Hypertension, Pulmonary / etiology*
  • Male
  • Middle Aged
  • Mutation
  • Receptors, Cell Surface / genetics
  • Telangiectasia, Hereditary Hemorrhagic / complications*
  • Telangiectasia, Hereditary Hemorrhagic / diagnosis
  • Telangiectasia, Hereditary Hemorrhagic / genetics

Substances

  • Antigens, CD
  • ENG protein, human
  • Endoglin
  • Genetic Markers
  • Receptors, Cell Surface
  • ACVRL1 protein, human
  • Activin Receptors, Type II
  • BMPR2 protein, human
  • Bone Morphogenetic Protein Receptors, Type II